Correlation Between Morgan Stanley and Creso Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Creso Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Creso Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morgan Stanley Direct and Creso Pharma Limited, you can compare the effects of market volatilities on Morgan Stanley and Creso Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Creso Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Creso Pharma.

Diversification Opportunities for Morgan Stanley and Creso Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Morgan and Creso is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Creso Pharma Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Creso Pharma Limited and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Creso Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Creso Pharma Limited has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Creso Pharma go up and down completely randomly.

Pair Corralation between Morgan Stanley and Creso Pharma

If you would invest  1,934  in Morgan Stanley Direct on September 17, 2024 and sell it today you would earn a total of  184.00  from holding Morgan Stanley Direct or generate 9.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy60.94%
ValuesDaily Returns

Morgan Stanley Direct  vs.  Creso Pharma Limited

 Performance 
       Timeline  
Morgan Stanley Direct 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Creso Pharma Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Creso Pharma Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Creso Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Morgan Stanley and Creso Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Morgan Stanley and Creso Pharma

The main advantage of trading using opposite Morgan Stanley and Creso Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Creso Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Creso Pharma will offset losses from the drop in Creso Pharma's long position.
The idea behind Morgan Stanley Direct and Creso Pharma Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Money Managers
Screen money managers from public funds and ETFs managed around the world